Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STVN · against 276 other Healthcare companies of similar size
Ranked #88 of 277 · scores higher than 67% of peers
Bars: peers in each 10-point band of the valuation score41 peers with a valuation score of 60–69, including STVN · Click a bar to see the companies
Mainly thanks to its EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | STVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 273 reported | 4.0% | 2.5% | 67% | 30% | |
| EBITDA yieldHigher is better · 272 reported | 7.9% | 4.8% | 75% | 50% | |
| Free cash flow yieldHigher is better · 146 reported | -0.9% | 0.9% | 42% | 20% | |
| Book yieldHigher is better · 271 reported | 43.8% | 28.1% | 69% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 5 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 85 | 5.2B CHF (≈$5.9B) | 69 | 69 | |
| 88 | 13.8B CNY (≈$1.9B) | 68 | 51 | |
| 88 | 2.4B USD | 68 | 64 | |
| 88 | 4.0B EUR (≈$4.4B) | 68 | 49 | |
| 88 | 3.9B USD | 68 | 58 | |
| 92 | 3.1B EUR (≈$3.4B) | 67 | 42 | |
| 92 | 170.4B THB (≈$4.8B) | 67 | 70 | |
| 92 | 2.7B CAD (≈$2.0B) | 67 | 54 | |
| 92 | 74.2B SEK (≈$7.4B) | 67 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score